ロード中...
CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery
Background/Aim: Pancreatic ductal adeno-carcinoma (PDAC) is one of the most aggressive types of digestive cancer. Recurrence within one year after surgery is inevitable in most PDAC patients. Recently, cluster of differentiation 44 (CD44) has been shown to be associated with tumor initiation, metast...
保存先:
| 出版年: | In Vivo |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Institute of Anticancer Research
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6365743/ https://ncbi.nlm.nih.gov/pubmed/30348713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11411 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|